Technical Data
S1014-52X
SMAD3 (Mothers Against Decapentaplegic Homolog 3, Mothers Against DPP Homolog 3, MAD Homolog 3, Mad3, SMAD Family Member 3, SMAD 3, Smad3, JV15-2, MADH3)
Description:
Smad3 is a 50kD transcriptional modulator activated by TGF-beta and activin type 1 receptor kinase, functioning in cell proliferation, differentiation and development. Upon stimulation, Smad3 oligomerizes with Smad4 and translocates into the nucleus and binds to DNA and transcription factors.

Smad3 activity induces differentiation of selected neuronal subtypes at the expense of other subtypes.

Applications:
Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
ELISA: 1:15,000-1:50,000
Western Blot: 1:500-1:1,000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
50ug-20°CBlue IceHumanRabbit
Concentration:
~1mg/ml
Immunogen:
Synthetic peptide corresponding to the internal region of human SMAD3.
Purity:
Purified by immunoaffinity chromatography.
Form
Supplied as a liquid in PBS, pH 7.2, 0.01% sodium azide.
Specificity:
Recognizes human Smad3. Species sequence homology: rat, mouse.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. García-Campmany, L. and Martí, E. (2007) The TGFbeta intracellular effector Smad3 regulates neuronal differentiation and cell fate specification in the developing spinal cord. Development. 134: 65-75.